PERYL COMBI 2mg/0.625mg tablets ICN POLFA RZESZOW
Active substance: perindopril + indapamide
C09BA04 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
Indicated for: hypertension
Find medicines for human use by name or active substance.
Browse by initial
561–580 of 1,444 medicines
Active substance: perindopril + indapamide
C09BA04 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
Indicated for: hypertension
Active substance: perindopril + indapamide
C09BA04 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
Indicated for: hypertension
Active substance: protionamide
Indicated for: tuberculosis
Active substance: valproic acid + salts
N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives
Indicated for: epilepsy; bipolar disorder
Active substance: ethosuximide
N03AD01 Nervous system | Antiepileptics | Antiepileptics | Succinimide derivatives
Indicated for: epilepsy
Active substance: ethosuximide
N03AD01 Nervous system | Antiepileptics | Antiepileptics | Succinimide derivatives
Indicated for: epilepsy
Active substance: ethosuximide
N03AD01 Nervous system | Antiepileptics | Antiepileptics | Succinimide derivatives
Indicated for: epilepsy
Active substance: febuxostat
Indicated for: gout; hyperuricemia
Active substance: risedronic acid
Indicated for: osteoporosis
Active substance: risedronic acid
Indicated for: osteoporosis
Active substance: febuxostat
Indicated for: gout; hyperuricemia
Active substance: pramipexole
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
Indicated for: Parkinson's disease
Active substance: pramipexole
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
Indicated for: Parkinson's disease
Active substance: caffeine citrate
Indicated for: apnea of prematurity
Active substance: polymaltose iron (III) hydroxide complex
B03AB05 Blood and blood forming organs | Iron preparations | Iron trivalent, oral preparations
Indicated for: iron deficiency; iron-deficiency anemia
Active substance: atorvastatin
Indicated for: dyslipidemia
Active substance: atorvastatin
Indicated for: dyslipidemia
Active substance: atorvastatin
Indicated for: dyslipidemia
Active substance: mirtazapine
N06AX11 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression
Active substance: mirtazapine
N06AX11 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.